Product Use Guide
Lipid P3B · DC60934 · Updated 29 October 2026
| Product | Lipid P3B |
|---|---|
| Catalog number | DC60934 |
| Synonyms | Lipid P3-B; P3B; P-3CR-Brain; H8TA2TB5 |
| CAS No. | Not available |
| Molecular formula | C41H76N2O3 |
| Molecular weight | 645.07 |
| SMILES | CCCCC/C=C\C/C=C\CCCCCCCC(OC(=O)CC1CCN(C)CC1)C(=O)NCCCCCCCCCCCCCC |
| Purity | >95% by ELSD-HPLC |
| Storage | Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light. |
| Shipping | Ships from Shanghai; ice-pack transport |
Solution calculations
Calculated from molecular weight 645.07. These volumes do not establish solubility or solvent compatibility.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 100 mg | 155.0219 mL | 31.0044 mL | 15.5022 mL |
| 250 mg | 387.5548 mL | 77.5110 mL | 38.7555 mL |
Handling and storage
Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light.
Handle small quantities with suitable laboratory protective equipment. Avoid contamination, moisture and repeated freeze–thaw cycles. Select a solvent using validated solubility information.
Literature formulation
The optimized PEG fraction and exact PEG-lipid identity remain under review. This guide does not provide a definitive preparation recipe.
View formulation records, in vivo data and original figures →
Reference
Dong S, Healy L, Gong F, et al. Biodegradable lipid nanoparticles for genome editing in the brain via intrathecal administration. Materials Today. 2026;92:140–150. doi:10.1016/j.mattod.2025.11.032.